Tolerion, Inc.   Report issue

For profit Phase 2
Founded: South San Francisco CA United States (2009)

Organization Overview

First Clinical Trial
2019
NCT03794973
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Tolerion, Inc.